Belluscura Information

Belluscura was established in the U.K. as a medical device company focused on developing oxygen enrichment technology to help improve health for Chronic Obstructive Pulmonary Disease (COPD) patients and more favorable economic outcomes for the patient, provider, and insurance companies. COPD is the third leading cause of death in the United States, affecting approximately 30 million people in the U.S. and over 100 million worldwide. Belluscura, now with North American headquarters located in Texas, is dedicated to developing proprietary, patented oxygen enrichment technologies that can be applied across a range of treatment possibilities and positively impact millions of people across the globe.

Website	https://www.belluscura.com
Revenue	$1 million
Employees	32 (1 on RocketReach)
Founded	2015
Address	15 Fetter Ln, London, Greater London EC4A 1BW, GB
Phone	+44 7863 911843
Technologies	JavaScript , HTML , PHP +25 more (view full list)
Industry	Manufacturing General, Medical Device, Manufacturing, Health Care
Web Rank	20 Million
Keywords	Copd Treatment, Pulmonary Disease, Oxygen Therapy, Respiratory Devices, Respiratory Care, Portable Oxygen, Breathing Support, Health Technology, Medical Technology, Chronic Disease, Treatment Devices, Home Healthcare, Lung Health, Healthcare Devices, Clinical Technology, Patient Care, Wellness Technology
Competitors	Medtronic, Philips, ResMed, Air Liquide, Air Products, Dräger, Invacare Corporation, Inogen, VitalAire, Drive DeVilbiss International +25 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies